Scientists launch better method to assess risks of endocrine disrupters

When the European Commission put forward a proposal to restrict the use of endocrine-disrupting chemicals, it quickly attracted criticism. One of the scientists who argued that it was too vague and not tough enough on chemicals producers was Christina Rudén, former programme director of MistraPharma.

At the same time, she and the other researchers presented a better method of assessing the risks associated with chemicals. Europe and the United States currently have different risk assessment procedures, which need to be harmonised.

‘Under the proposal,’ Rudén said, ‘you have to demonstrate that people have been both exposed to and harmed by a chemical before it can be restricted. The standard of proof is extremely high. That means that industry will still be able to use and sell many of these substances.’